Canadian algae technology company Solarvest BioEnergy has been granted a patent for algal-based omega-3 production in Brazil, Newswire reported.
The patent covered the production of algal biomass, algal cell cultures, lipid compounds and compositions, including fatty acids, carotenoids and fat soluble vitamins, the 24 January report said.
On its website, Solarvest said it had researched and developed microalgae strains for a range of markets, including health products, pharmaceutical products and clean energy.
Marketing its omega-3 products through its wholly-owned subsidiary Eversea, the company’s patented omega-3 active ingredient had obtained US Food and Drug Administration (FDA) New Dietary Ingredient (NDI) certification and had been certified organic by the United States Department of Agriculture (USDA) and the European Union (EU), the company said.
In addition to the latest patent, the company had been granted organic omega-3 patents in Australia, India and Japan, Newswire wrote, with patents pending in many other global markets including the EU and the USA.
The company is currently extending its portfolio to include cannabinoids, according to its website.
